Moonypto | Crypto News & Market Analysis: post #5750 — TG.ME

Moderna’s story is shifting from a COVID vaccine company toward a broader mRNA platform, and the biggest potential catalyst is its personalized cancer immunotherapy The concept is built around identifying mutations unique to a patient’s tumor, creating a…